The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Hyperuricemia and incident hypertension: A systematic review and meta‐analysis
Open accessAbstract
Objective: A novel rodent model and a recent randomized trial of hyperuricemic adolescents with hypertension suggest a pathogenetic role of uric acid in hypertension, but it remains unknown whether these findings would be applicable to adult populations where the larger disease burden exists. We conducted a systematic review and meta‐analysis to determine if hyperuricemia was associated with incident hypertension, particularly in various demographic subgroups. Methods: We searched major electronic databases using medical subject headings and keywords without language restrictions (through April 2010). We included prospective cohort studies with data on incident hypertension related to serum uric acid levels. Data abstraction was conducted in duplicate. We analyzed age, sex, and race subgroups. Results: A total of 18 prospective cohort studies representing data from 55,607 participants were included. Hyperuricemia was associated with an increased risk for incident hypertension (adjusted risk ratio [RR] 1.41, 95% confidence interval [95% CI] 1.23–1.58). For a 1 mg/dl increase in uric acid level, the pooled RR for incident hypertension after adjusting for potential confounding was 1.13 (95% CI 1.06–1.20). These effects were significantly larger in younger study populations (P = 0.02) and tended to be larger in women (P = 0.059). Two studies suggested that the effect may also be larger among African American individuals. Furthermore, later publication year and US‐based studies were significantly associated with a lower effect estimate (P values <0.02). Conclusion: Hyperuricemia is associated with an increased risk for incident hypertension, independent of traditional hypertension risk factors. This risk appears more pronounced in younger individuals and women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580
Funnel plots for detecting bias in meta-analysis
Sterne, J. A. C., & Egger, M. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(01)00377-8 · Cited by 3,779
meta-analysis bias in location and selection of studies
Egger, M., & Smith, G. D. (1998) · BMJ · doi:10.1136/bmj.316.7124.61 · Cited by 1,374
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Cited by
Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
Zhu, Y., Pandya, B. J., & Choi, H. K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.033 · Cited by 655
Self-citationJohnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179221 · Cited by 595
Arterial hypertension in adults. Clinical guidelines 2020
Kobalava, Z. D., Konradi, A. O., Nedogoda, S. V., Shlyakhto, E. V., Arutyunov, G. P., Baranova, E. I., Barbarash, O. L., Boitsov, S. A., Vavilova, T. V., Villevalde, S. V., et al. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3-3786 · Cited by 541
Te Morenga, L. A., Howatson, A. J., Jones, R. M., & Mann, J. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081521 · Cited by 509
Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
Gherghina, M.-E., Peride, I., Tiglis, M., Neagu, T. P., Niculae, A., & Checherita, I. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063188 · Cited by 501
Definition of hyperuricemia and gouty conditions
Bardin, T., & Richette, P. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000028 · Cited by 499
Serum uric acid and the risk of cardiovascular and renal disease
Borghi, C., Rosei, E. A., Bardin, T., Dawson, J., Dominiczak, A., Kielstein, J. T., Manolis, A. J., Perez-Ruiz, F., & Mancia, G. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000701 · Cited by 463
Gout epidemiology and comorbidities
Singh, J. A., & Gaffo, A. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.04.008 · Cited by 456
The role of uric acid in the pathogenesis of human cardiovascular disease
Kanbay, M., Segal, M., Afsar, B., Kang, D.-H., Rodriguez-Iturbe, B., & Johnson, R. J. (2013) · Heart · doi:10.1136/heartjnl-2012-302535 · Cited by 454
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Borghi, C., Agabiti-Rosei, E., Johnson, R. J., Kielstein, J. T., Lurbe, E., Mancia, G., Redon, J., Stack, A. G., & Tsioufis, K. P. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.006 · Cited by 435
Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K. K., Ioannidis, P. A., Campbell, H., & Theodoratou, E. (2017) · BMJ · doi:10.1136/bmj.j2376 · Cited by 385
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Bardin, T., & Richette, P. (2017) · BMC Medicine · doi:10.1186/s12916-017-0890-9 · Cited by 385
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Yu, W., & Cheng, J.-D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582680 · Cited by 344
Wang, J., Qin, T., Chen, J., Li, Y., Wang, L., Huang, H., & Li, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114259 · Cited by 341
URic Acid and Risk Of Heart Failure: A Systematic Review and Meta-Analysis
Huang, H., Huang, B., Li, Y., Huang, Y., Li, J., Yao, H., Jing, X., Chen, J., & Wang, J. (2014) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft132 · Cited by 339
Asymptomatic hyperuricaemia: a silent activator of the innate immune system
Joosten, L. A. B., Crişan, T. O., Bjornstad, P., & Johnson, R. J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0334-3 · Cited by 319
Zhao, G., Huang, L., Song, M., & Song, Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.08.023 · Cited by 282
The ongoing pursuit of neuroprotective therapies in Parkinson disease
Athauda, D., & Foltynie, T. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.226 · Cited by 269
Allopurinol and Cardiovascular Outcomes in Adults With Hypertension
MacIsaac, R. L., Salatzki, J., Higgins, P., Walters, M. R., Padmanabhan, S., Dominiczak, A. F., Touyz, R. M., & Dawson, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06344 · Cited by 124
Shirakura, T., Nomura, J., Matsui, C., Kobayashi, T., Tamura, M., & Masuzaki, H. (2016) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-016-1239-1 · Cited by 36
Yang, Y., Gu, M., Wang, W., Li, S., Lu, J., Sun, Q., Hu, M., & Zhong, L. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01316-0 · Cited by 10
Metadata
- Authors
- Grayson, P. C., Kim, S. Y., LaValley, M., & Choi, H. K.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2010-12-28
- Volume
- 63
- Issue
- 1
- Pages
- 102-110
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W1757751439
- Cited by
- 756
- References
- 45
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.